Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.
about
Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segmentDisruption of parallel and converging signaling pathways contributes to the synergistic antitumor effects of simultaneous mTOR and EGFR inhibition in GBM cellsAn integrated genomic analysis of human glioblastoma multiformeG protein-coupled receptors as oncogenic signals in glioma: emerging therapeutic avenuesTargeted molecular therapies against epidermal growth factor receptor: past experiences and challengesCurrent Understanding on EGFR and Wnt/β-Catenin Signaling in Glioma and Their Possible CrosstalkWill kinase inhibitors make it as glioblastoma drugs?Heterogeneity of epidermal growth factor receptor signalling networks in glioblastomaFingolimod for the treatment of neurological diseases-state of play and future perspectivesTransmigration of neural stem cells across the blood brain barrier induced by glioma cellsUnderstanding the Impact of ErbB Activating Events and Signal Transduction on Antigen Processing and Presentation: MHC Expression as a Model.Afatinib, an irreversible ErbB family blocker, with protracted temozolomide in recurrent glioblastoma: a case report.Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domainEpidemiologic and molecular prognostic review of glioblastomaInhibition of cell proliferation by an anti-EGFR aptamerPolymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancersPhase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177.Cell cycle and aging, morphogenesis, and response to stimuli genes are individualized biomarkers of glioblastoma progression and survival.Analysis of differentially expressed genes based on microarray data of glioma.Polymorphisms in the epidermal growth factor receptor gene and the risk of primary lung cancer: a case-control study.Glial progenitor-like phenotype in low-grade glioma and enhanced CD133-expression and neuronal lineage differentiation potential in high-grade glioma.Exon expression arrays as a tool to identify new cancer genes.Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics.Genetics of glioblastoma: a window into its imaging and histopathologic variability.Clinical significance of EGFR amplification and the aberrant EGFRvIII transcript in conventionally treated astrocytic gliomas.Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA.Singular Value Decomposition-based Alternative Splicing Detection.EGFRvIII-targeted vaccination therapy of malignant glioma.Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical developmentOncogenic mutant forms of EGFR: lessons in signal transduction and targets for cancer therapy.Mesenchymal migration as a therapeutic target in glioblastoma.EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencing.Antibody-based immunotherapy for malignant glioma.Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial.Cord blood stem cells inhibit epidermal growth factor receptor translocation to mitochondria in glioblastoma.Combination of phosphorylated and truncated EGFR correlates with higher tumor and nodal stage in head and neck cancerAn epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiformeKinase-mediated quasi-dimers of EGFREpidermal growth factor receptor and variant III targeted immunotherapy.
P2860
Q24309071-28DB712A-D3B5-4392-962D-E814D26A3FF0Q24550891-AB01EC18-8C0D-44E2-8409-C71B2EF9D037Q24648860-65E4C9FC-3509-4196-9CF0-9110B8B581E7Q26825769-324FFCBA-7F31-48B0-87B3-D59986A21274Q26862516-D453837C-5112-4BC1-87C9-88C121CC6497Q26865911-A8CB2F26-F1DE-4DDB-9FEA-666CF412D73AQ27012684-27712ABF-0522-4E8C-913E-5BD183ED28C2Q27013006-6761F368-B470-4BB7-A30E-A808E6F0C7CBQ27026175-043742AD-FE23-4561-9FA4-FB18F84BEC6CQ27329613-57EDBD42-825F-45BA-A07A-163032E86C60Q27691330-A4FA5703-4FFC-42AD-AD7B-ABF45616EA5DQ27853219-C65593E8-06D8-43D8-9642-18B1561CF36BQ27865182-0A972290-5807-4A5E-9AC3-845318711663Q28395302-81584866-C382-4590-9679-C66F55614310Q28743866-B2FD9AAD-25E7-4C1F-A0BF-BAA7ABACDD23Q28757672-0B684A74-3F18-4861-BC18-BA5A238521A3Q30437778-7006A775-D572-4E03-B82B-036F25C099E6Q31016728-B5AFEE2E-0441-4386-993F-FA304E24ABC3Q31037039-043EE154-E088-447F-B865-08E4F17A7400Q33303639-9ED66863-3B09-4F52-8433-910E5E79B7BEQ33327359-3F50C9E1-DFC4-4C73-9EF0-2489C5156FCFQ33358687-B4F876DE-0BF8-4A36-B9C3-960D99E3A771Q33407127-3FD37832-3308-4EB2-B66F-4552B243840BQ33601653-93BFC4D2-0A92-45E7-AE4D-A7533C970546Q33620506-A76CE3D4-56F1-4C11-9E0B-AE6294D016D3Q33628302-9B3432E7-0548-40C8-BFDB-4F0D40E58933Q33725972-41439963-5B0B-44F5-8E2C-D7982DA23D35Q33738044-B694D700-A208-4677-87D0-35C2246730ADQ33758459-CCD56ADA-4338-4B14-ACBB-D5DAEB87F4A9Q33776641-D48E930C-07ED-42A2-86DD-0EAC5952DD47Q33943421-58167ED7-70E9-43BF-9935-387E9902F443Q34002994-DAE934DC-956B-4771-99D5-7947ADA52B60Q34016908-14218EE1-4C61-4DC4-B08C-E1F6EB39F478Q34120472-51EFC955-45BF-4A9D-B5D2-4598FB9E527BQ34132872-73570196-22AA-4271-B733-6E11494F6FD5Q34163778-A2F76BE7-DB1B-48FA-B68F-1F30E42B4F9CQ34318204-4AA2A391-96EE-4496-B82B-0BBEA92F5B45Q34346944-2ABBB681-DDE0-4523-8A02-0C4E7A097741Q34352792-0A74F2E0-4353-4275-9605-89761D013164Q34391942-2949CA89-5AE0-424C-9AAB-64CB928C21F1
P2860
Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Diversity and frequency of epi ...... ations in human glioblastomas.
@en
Diversity and frequency of epi ...... ations in human glioblastomas.
@nl
type
label
Diversity and frequency of epi ...... ations in human glioblastomas.
@en
Diversity and frequency of epi ...... ations in human glioblastomas.
@nl
prefLabel
Diversity and frequency of epi ...... ations in human glioblastomas.
@en
Diversity and frequency of epi ...... ations in human glioblastomas.
@nl
P2093
P1433
P1476
Diversity and frequency of epi ...... tations in human glioblastomas
@en
P2093
P304
P407
P577
2000-03-01T00:00:00Z